Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: August 22, 2017
| Title: | Method of computed tomography using fluorinated gas-filled lipid microspheres as contract agents |
| Abstract: | Novel gas filled microspheres useful as computed tomography (CT) contrast agents. The microspheres are prepared from a gas and/or a gaseous precursor, and one or more stabilizing compounds. |
| Inventor(s): | Unger; Evan C. (Tucson, AZ) |
| Assignee: | ImaRx Pharmaceutical Corp. (Tucson, AZ) |
| Filing Date: | Nov 10, 1997 |
| Application Number: | 08/968,776 |
| Claims: | 1. A method of providing an image of an internal region of a patient comprising (i) administering to the patient a composition comprising, in an aqueous carrier, gas-filled microspheres, wherein said gas comprises a fluorinated gas selected from the group consisting of perfluorocarbons and sulfur hexafluoride, and said microspheres comprise a biocompatible lipid, bearing a hydrophilic polymer, said hydrophilic polymer covalently bound to said biocompatible lipid through an amide, carbamate, amine, ester, ether thioester or thioamide linkage, and (ii) scanning the patient using computed tomography to obtain visible images of the region. 2. A method according to claim 1 wherein the region comprises the vasculature. 3. A method according to claim 1 wherein the region comprises the cardiovascular region. 4. A method according to claim 1 wherein the region comprises the gastrointestinal region. 5. A method for diagnosing the presence of diseased tissue in a patient comprising (i) administering to the patient a composition comprising, in an aqueous carrier, gas-filled microspheres, wherein said gas comprises a fluorinated gas selected from the group consisting of perfluorocarbons and sulfur hexafluoride, and said microspheres comprise a biocompatible lipid bearing a hydrophilic polymer, said hydrophilic polymer covalently bound to said biocompatible lipid through an amide, carbamate, amine, ester, ether, thioester or thioamide region. 6. A method according to claim 5 wherein the region comprises the vasculature. 7. A method according to claim 5 wherein the region comprises the cardiovascular region. 8. A method according to claim 5 wherein the region comprises the gastrointestinal region. 9. A method according to claim 5 wherein said scanning is of a region of a patient selected from the group consisting of the intranasal tract, the auditory canal, the intraocular region, the intraperitoneal region, the kidneys, the urethra and the genitourinary tract. |
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,377 others who get our Drug Patent Expiration Alerts:
